FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hutchison Patrick

2. Date of Event Requiring Statement (MM/DD/YYYY)
4/30/2016 

3. Issuer Name and Ticker or Trading Symbol

TETRALOGIC PHARMACEUTICALS CORP [TLOG]

(Last)        (First)        (Middle)

C/O TETRALOGIC PHARMACEUTICALS CORP., 343 PHOENIXVILLE PIKE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
CFO & Treasurer /

(Street)

MALVERN, PA 19355       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   7000   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Purchase)     (1) 2/24/2024   Common Stock   25000   $7.72   D  
 
Stock Option (Right to Purchase)     (2) 3/18/2025   Common Stock   11500   $4.51   D  
 

Explanation of Responses:
( 1)  13,530 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on February 24, 2014. Twenty-five percent (25%) of the option shares vested and became exercisable on February 24, 2015. The remainder vest monthly, beginning on March 24, 2015, at a rate of 520 shares per month for thirty-five (35) months following March 24,2015 and a rate of 550 shares in the thirty-sixth month.
( 2)  3,120 option shares are currently exercisable. The option shares vest and become exercisable over a four-year period that commenced on April 18, 2015. The option shares vest monthly at a rate of 240 shares per month for forty-seven (47) months following April 18, 2015 and a rate of 220 shares in the forty-eighth month.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hutchison Patrick
C/O TETRALOGIC PHARMACEUTICALS CORP.
343 PHOENIXVILLE PIKE
MALVERN, PA 19355

CFO & Treasurer

Signatures
/s/ Richard Sherman, Attorney-In-Fact for Patrick Hutchison 5/9/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
TetraLogic Pharmaceuticals (CE) (USOTC:TLOG)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 TetraLogic Pharmaceuticals (CE) 차트를 더 보려면 여기를 클릭.
TetraLogic Pharmaceuticals (CE) (USOTC:TLOG)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 TetraLogic Pharmaceuticals (CE) 차트를 더 보려면 여기를 클릭.